is tirzepatide a glp1 Semaglutide vs 💉⚖️ Both are powerful medications for diabetes and weight loss, but tirzepatide's dual GIP + GLP-1 action may lead to even greater weight loss and glucose control. Semaglutide offers Pharmacogenomics of Tirzepatide: Genomic Insights

In this episode: Why patients who stop GLP-1 therapy often return The first weeks of Medicare's obesity medication coverage The future of oral GLP-1 medications New implant technology from Novo Nordisk Muscle-preserving obesity treatments Why patient experience is becoming the next frontier in obesity medicine The goal of On The Pen has always been simple: translate complex obesity and diabetes news into information that helps you have better conversations with your doctor

At 72 weeks, tirzepatide 15 mg produced 15.7% mean weight reduction versus 3.3% with placebo [6]

Sobre la obesidad La obesidad es una enfermedad[1]que requiere un manejo crnico

doi:10.3762/bjoc.4.39

No aeromedically significant side effects: You must have no cognitive, neurologic or other impairing symptoms (e.g., disabling GI effects, dizziness, somnolence)